Clinical Breast Cancer

Clinical Breast Cancer is a bimonthly peer-reviewed journal published by Elsevier, established in 2000 and devoted to the detection, diagnosis, prevention and treatment of breast cancer, with a 2025 impact factor of 2.7（Clinical Breast Cancer）是由 Elsevier 出版的双月刊同行评审期刊，2000 年创办，专注乳腺癌的筛查、诊断、预防与治疗，2025 年影响因子为 2.7。

Scope

• It focuses on recent scientific developments in every area related to breast cancer关注与乳腺癌相关的各领域最新科学进展。
• Clinical research reports across therapeutic modalities form a central part of its content跨治疗手段的临床研究报告是其核心内容。
• Cancer genetics, drug sensitivity and resistance, and novel imaging are all covered涵盖肿瘤遗传学、药物敏感性与耐药性以及新型影像学。
• Tumour genomics, biomarkers and chemoprevention strategies are further areas of interest肿瘤基因组学、生物标志物与化学预防策略也是其重点方向。
• The journal publishes original contributions, comprehensive reviews, case reports and commentaries刊载原创论文、综合综述、病例报告与评论。

History

• The journal was established in 2000, with its first issue dated April 2000该刊创办于 2000 年，首期为 2000 年 4 月。
• It has been published by Elsevier since 20112011 年起由 Elsevier 出版。
• It appears bimonthly, issuing eight issues a year该刊双月出版，每年八期。
• Copies were distributed free of charge to US medical, surgical, radiation and gynaecological oncologists早期曾向美国内科、外科、放疗与妇科肿瘤医师免费赠阅。

Editors

• The editor-in-chief is Ruth O'Regan, MD现任主编为 Ruth O'Regan。
• The editorial board is made up of prominent clinical and translational oncology leaders编委会由临床与转化肿瘤学领域的知名专家组成。
• Each issue features peer-reviewed original contributions, reviews and case reports每期刊载经同行评审的原创论文、综述与病例报告。
• Its readership is primarily medical oncologists, haematologists and surgical oncologists读者主要为肿瘤内科、血液科与肿瘤外科医师。